Trial Profile
A phase II trial of Cyclosporin A in Early Adverse Risk CLL
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2019
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Pharmacodynamics
- Acronyms CyCLLe
- 06 Jul 2017 Status changed from recruiting to completed.
- 29 Mar 2016 Accrual to date is 50% according to United Kingdom Clinical Research Network record.
- 06 Sep 2013 Accrual to date is 10% according to United Kingdom Clinical Research Network record.